Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Isoform Selective HDAC8 Inhibitor (OCH3) Shows Potency in Selectively Targeting Primary AML Cells

Amal Mechaal, Amudha Ganapathy, Dolores Mahmud, Taha Y Taha, Rajeev Ranjan, Irum Khan, Pavel Petukhov, Nadim Mahmud

Blood (2021) 138 (Supplement 1): 2944.

https://doi.org/10.1182/blood-2021-151599

Published: 2021

Journal Articles

Monitoring of Stored Hematopoietic Stem/Progenitor Graft Stability Program in a Single Institute

Youngmin Park, MS, Grace Irene, BS, Amudha Ganapathy, PhD, Dolores Mahmud, PhD, Pritesh Patel, MB, ChB, Damiano Rondelli, MD, Nadim Mahmud, MBBS, PhD

Blood (2019) 134 (Supplement_1): 1968.

https://doi.org/10.1182/blood-2019-132145

Published: 2019

Journal Articles

PARP Inhibitor Veliparib and Busulfan in a Xenograft Model of Myeloproliferative Neoplasm

Pritesh Patel, MD, Vitalyi Senyuk, PhD, Natalie S. Rodriguez, MS, Dolores Mahmud, PhD, Annie Lee Oh, MD, Nadim Mahmud, MBBS, PhD, Giovanni Barosi, MD, Damiano Rondelli, MD

Blood (2018) 132 (Supplement 1): 3319.

https://doi.org/10.1182/blood-2018-99-119497

Published: 2018

Journal Articles

Multi-Phase Ex Vivo Generation of Platelet-like Particles from CD34 + Cord Blood Cell-Derived Megakaryocytes

Jia J. Wu, BS, Darryl A. Abbott, BS, Meryem K. Terzioglu, MD, Rajeev Ranjan, PhD, Dolores Mahmud, PhD, Hasan Issa, MBBch, Neda Bagheri, PhD, Nadim Mahmud, MBBS, PhD, William M. Miller, PhD

Blood (2017) 130 (Supplement 1): 3196.

https://doi.org/10.1182/blood.V130.Suppl_1.3196.3196

Published: 2017

Journal Articles

Generation of Megakaryocytes and Platelets from Valproic Acid Expanded Human Cord Blood CD34+ Cells in Culture

Nadim Mahmud, MBBS, PhD, Rajeev Ranjan, PhD, Jia J. Wu, BS, Benjamin Petro, Meryem K. Terzioglu, MD, Hasan Issa, MBBch, Darryl A. Abbott, BS, Dolores Mahmud, PhD, William M. Miller, PhD

Blood (2017) 130 (Supplement 1): 3751.

https://doi.org/10.1182/blood.V130.Suppl_1.3751.3751

Published: 2017

Journal Articles

Gaussian Mixture Models and Machine Learning Predict Megakaryocytic Growth and Differentiation Potential Ex Vivo

Jia J. Wu, BS, Darryl A. Abbott, BS, Meryem K. Terzioglu, MD, Dolores Mahmud, PhD, Nadim Mahmud, MBBS, PhD, William M. Miller, PhD, Neda Bagheri, PhD

Blood (2017) 130 (Supplement 1): 4474.

https://doi.org/10.1182/blood.V130.Suppl_1.4474.4474

Published: 2017

Journal Articles

The Cytotoxic Effect of the PARP Inhibitor ABT-888 on Myeloproliferative Neoplasms

Pritesh R. Patel, MB, ChB, Vitalyi Senyuk, PhD, Elisa Bonetti, PhD, Dolores Mahmud, PhD, Shrihari S. Kadkol, MD PhD, Annie L. Oh, MD, Nadim Mahmud, MD PhD, Damiano Rondelli, MD

Blood (2016) 128 (22): 4276.

https://doi.org/10.1182/blood.V128.22.4276.4276

Published: 2016

Journal Articles

C75 Fatty Acid Synthesis (FAS) Inhibitor Has Potent Immunosuppressive Activity

Vitalyi Senyuk, PhD, Dolores Mahmud, PhD, Annie L. Oh, MD, Pritesh R. Patel, MD, Damiano Rondelli, MD

Blood (2016) 128 (22): 2156.

https://doi.org/10.1182/blood.V128.22.2156.2156

Published: 2016

Journal Articles

In-Vitro and in-Vivo Synergistic Effect of Melphalan and Dual DNA Repair Inhibition in Multiple Myeloma

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Vitalyi Senyuk, PhD, Dolores Mahmud, PhD, Nadim Mahmud, MD PhD, Damiano Rondelli, MD

Blood (2016) 128 (22): 3301.

https://doi.org/10.1182/blood.V128.22.3301.3301

Published: 2016

Journal Articles

Dual DNA Damage Repair Inhibition Synergizes with Alkylator Chemotherapy for Myeloma and Acute Leukemia

Pritesh R. Patel, MB, ChB, Vitalyi Senyuk, PhD, Dolores Mahmud, PhD, Annie L. Oh, MD, Damiano Rondelli, MD

Blood (2015) 126 (23): 2053.

https://doi.org/10.1182/blood.V126.23.2053.2053

Published: 2015

Journal Articles

Preclinical Study for the Use of Abatacept to Prevent Rejection of Allogeneic CD34+ Cells in a Xenograft Model

Annie L. Oh, MD, Dolores Mahmud, PhD, Vitalyi Senyuk, PhD, Elisa Bonetti, PhD, Nadim Mahmud, MD PhD, Pritesh R. Patel, MB, ChB, Damiano Rondelli, MD

Blood (2015) 126 (23): 4271.

https://doi.org/10.1182/blood.V126.23.4271.4271

Published: 2015

Journal Articles

Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)

Santosh L. Saraf, MD, Annie L. Oh, MD, Dolores Mahmud, PhD, Pritesh R. Patel, MB, ChB, Karen Sweiss, PharmD, Matthew Koshy, MD, Sally Campbell-Lee, MD, Michel Gowhari, DO, Johara Hassan, MD, David Peace, MD, John G. Quigley, MD, Irum Khan, MBBS, Robert E. Molokie, MD, Lewis L. Hsu, MD PhD, Nadim Mahmud, MD PhD, Dennis J Levinson, MD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2014) 124 (21): 2703.

https://doi.org/10.1182/blood.V124.21.2703.2703

Published: 2014

Journal Articles

Synergistic Cytotoxic Effect Of The PARP Inhibitor ABT888 and Busulfan In Acute Leukemia Cell Lines

Pritesh R. Patel, MB, ChB, Dolores Mahmud, Ph.D., Damiano Rondelli, MD

Blood (2013) 122 (21): 4936.

https://doi.org/10.1182/blood.V122.21.4936.4936

Published: 2013

Journal Articles

Co-Stimulatory Blockade With CTLA4-Ig Permits Transplantation Of Human Hematopoietic Stem Cells and HLA Incompatible T Cells In NOD/SCID γ Null (NSG) Mouse Model

Annie L. Oh, MD, Dolores Mahmud, Ph.D., Benedetta Nicolini, Ph.D., Nadim Mahmud, MD, PhD, Elisa Bonetti, BS, Pritesh R. Patel, MB, ChB, Damiano Rondelli, MD

Blood (2013) 122 (21): 1999.

https://doi.org/10.1182/blood.V122.21.1999.1999

Published: 2013

Journal Articles

Genomic Signature Predicts Resistance To Busulfan In AML Cell Lines

Pritesh R. Patel, MB, ChB, Dolores Mahmud, Ph.D., Wei Zhang, PhD, Joe GN Garcia, MD, Damiano Rondelli, MD

Blood (2013) 122 (21): 3850.

https://doi.org/10.1182/blood.V122.21.3850.3850

Published: 2013

Journal Articles

Anti-Leukemic Activity Is Increased with Low Dose Busulfan and Irradiation: A Preclinical Model

Pritesh R. Patel, MB, ChB, Dolores Mahmud, PhD, Wei Zhang, PhD, Tong Zhou, PhD, Nadim Mahmud, MD, PhD, Ralph R Weichselbaum, MD, Joe GN Garcia, MD, Damiano Rondelli, MD

Blood (2011) 118 (21): 4696.

https://doi.org/10.1182/blood.V118.21.4696.4696

Published: 2011

Journal Articles

Possible Reduced Immunogenicity of Chromatin Modifying Agents Expanded Cord Blood Grafts Is Likely Due to STAT3 Inhibition,

Benjamin Petro, BS, Kazumi G Yoshinaga, MS, Dolores Mahmud, PhD, Simona Taioli, MS, Santosh Saraf, MD, Amer Sidani, MD, John G. Quigley, MD, Damiano Rondelli, MD, Nadim Mahmud, MD, PhD

Blood (2011) 118 (21): 4016.

https://doi.org/10.1182/blood.V118.21.4016.4016

Published: 2011

Journal Articles

Clinical Grade Isolation of Regulatory T Cells From G-CSF Mobilized PBSC Improves with Initial Depletion of Monocytes.

Dolores Mahmud, Youngmin Park, Nadim Mahmud, MD, PhD, Damiano Rondelli

Blood (2010) 116 (21): 1176.

https://doi.org/10.1182/blood.V116.21.1176.1176

Published: 2010

Journal Articles

An in-Vivo Model of T Cell-Mediated Rejection of Human Hematopoietic CD34+ Stem Cells Using NOD/SCID γ null (NOG) Mice.

Benedetta Nicolini, Dolores Mahmud, PhD, Nadim Mahmud, MD, PhD, Giuseppina Nucifora, PhD, Damiano Rondelli, MD

Blood (2009) 114 (22): 4474.

https://doi.org/10.1182/blood.V114.22.4474.4474

Published: 2009

Journal Articles

Regulatory T Cells (Tregs) Can Be Isolated from G-CSF Mobilized PBSC after Monocyte Depletion and Inhibit Anti-Stem Cell T Cell Alloreactivity

Dolores Mahmud, PhD, Damiano Rondelli, MD

Blood (2008) 112 (11): 3477.

https://doi.org/10.1182/blood.V112.11.3477.3477

Published: 2008

NARROW

Isoform Selective HDAC8 Inhibitor (OCH3) Shows Potency in Selectively Targeting Primary AML Cells

Monitoring of Stored Hematopoietic Stem/Progenitor Graft Stability Program in a Single Institute

PARP Inhibitor Veliparib and Busulfan in a Xenograft Model of Myeloproliferative Neoplasm

Multi-Phase Ex Vivo Generation of Platelet-like Particles from CD34 + Cord Blood Cell-Derived Megakaryocytes

Generation of Megakaryocytes and Platelets from Valproic Acid Expanded Human Cord Blood CD34+ Cells in Culture

Gaussian Mixture Models and Machine Learning Predict Megakaryocytic Growth and Differentiation Potential Ex Vivo

The Cytotoxic Effect of the PARP Inhibitor ABT-888 on Myeloproliferative Neoplasms

C75 Fatty Acid Synthesis (FAS) Inhibitor Has Potent Immunosuppressive Activity

In-Vitro and in-Vivo Synergistic Effect of Melphalan and Dual DNA Repair Inhibition in Multiple Myeloma

Dual DNA Damage Repair Inhibition Synergizes with Alkylator Chemotherapy for Myeloma and Acute Leukemia

Preclinical Study for the Use of Abatacept to Prevent Rejection of Allogeneic CD34+ Cells in a Xenograft Model

Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)

Synergistic Cytotoxic Effect Of The PARP Inhibitor ABT888 and Busulfan In Acute Leukemia Cell Lines

Co-Stimulatory Blockade With CTLA4-Ig Permits Transplantation Of Human Hematopoietic Stem Cells and HLA Incompatible T Cells In NOD/SCID γ Null (NSG) Mouse Model

Genomic Signature Predicts Resistance To Busulfan In AML Cell Lines

Anti-Leukemic Activity Is Increased with Low Dose Busulfan and Irradiation: A Preclinical Model

Possible Reduced Immunogenicity of Chromatin Modifying Agents Expanded Cord Blood Grafts Is Likely Due to STAT3 Inhibition,

Clinical Grade Isolation of Regulatory T Cells From G-CSF Mobilized PBSC Improves with Initial Depletion of Monocytes.

An in-Vivo Model of T Cell-Mediated Rejection of Human Hematopoietic CD34+ Stem Cells Using NOD/SCID γ null (NOG) Mice.

Regulatory T Cells (Tregs) Can Be Isolated from G-CSF Mobilized PBSC after Monocyte Depletion and Inhibit Anti-Stem Cell T Cell Alloreactivity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only